Bohdan Chopko, MD, PhD

  • Professor of Neurosurgery and Complex Spine—Stanford University
  • Doctor of Medicine, Northeastern Ohio Universities College of Medicine
  • Ph.D. Neuroscience Kent State University
  • Resident, neurological surgery training program, UC San Diego 
​Houdin Dehnad, Ph.D.  

  • 20+ years Med Tech early technology development
  • Focus on implant material design in embolic coils, stents and polymer materials
  • Previous experiences with Alza, Micrus & Guidant
  • BS Chemical Engineering, Washington University; MS and Ph.D. University of Minnesota 


​​​​​​​​​​​Silver Bullet is developing OrthoFuzIon™​, an antimicrobial coating based on proprietary silver ionization technology designed to prevent contaminations associated with medical device implants.

             

             There is a significant clinical need to prevent bacteria from contaminating patients upon medical device implantation   

     

               The CMS “Bundled Payments for Care Improvement” (BPCI) may be a dramatic driving force for market adoption of OrthoFuzIon™ and Galvanis Technology

​

             Over 10 years of development, testing, and animal trials have enabled technology perfection


​

  

​








Founders

Paul Chirico, President & CEO

  • 30+  years in Med Tech, 20+ years in orthopedics/spine
  • Founder/CEO SpineAlign Medical
  • Previous experiences with Micrus Endovascular, Incyte Genomics & Avocet Medical
  • BS Biology/MBA Accounting, Santa Clara University 

Silver Bullet Therapeutics is committed to providing innovative medical devices that meet regulatory and customer requirements while maintaining an effective quality system. This is through teamwork and operational excellence that challenge the norm of medical care.

About Silver Bullet

NOT FOR FOR SALE IN UNITED STATES OF AMERICA

​NOT FDA CLEARED

​SILVER BULLET THERAPEUTICS QUALITY POLICY